Mandel Silvia A, Avramovich-Tirosh Yael, Reznichenko Lydia, Zheng Hailin, Weinreb Orly, Amit Tamar, Youdim Moussa B H
Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research, Technion-Faculty of Medicine, Haifa, Israel.
Neurosignals. 2005;14(1-2):46-60. doi: 10.1159/000085385.
Many lines of evidence suggest that oxidative stress resulting in reactive oxygen species (ROS) generation and inflammation play a pivotal role in the age-associated cognitive decline and neuronal loss in neurodegenerative diseases including Alzheimer's (AD), Parkinson's (PD) and Huntington's diseases. One cardinal chemical pathology observed in these disorders is the accumulation of iron at sites where the neurons die. The buildup of an iron gradient in conjunction with ROS (superoxide, hydroxyl radical and nitric oxide) are thought to constitute a major trigger in neuronal toxicity and demise in all these diseases. Thus, promising future treatment of neurodegenerative diseases and aging depends on availability of effective brain permeable, iron-chelatable/radical scavenger neuroprotective drugs that would prevent the progression of neurodegeneration. Tea flavonoids (catechins) have been reported to possess potent iron-chelating, radical-scavenging and anti-inflammatory activities and to protect neuronal death in a wide array of cellular and animal models of neurological diseases. Recent studies have indicated that in addition to the known antioxidant activity of catechins, other mechanisms such as modulation of signal transduction pathways, cell survival/death genes and mitochondrial function, contribute significantly to the induction of cell viability. This review will focus on the multifunctional properties of green tea and its major component (-)-epigallocatechin-3-gallate (EGCG) and their ability to induce neuroprotection and neurorescue in vitro and in vivo. In particular, their transitional metal (iron and copper) chelating property and inhibition of oxidative stress.
许多证据表明,导致活性氧(ROS)生成的氧化应激和炎症在包括阿尔茨海默病(AD)、帕金森病(PD)和亨廷顿病在内的神经退行性疾病的年龄相关性认知衰退和神经元丧失中起关键作用。在这些疾病中观察到的一个主要化学病理学现象是铁在神经元死亡部位的积累。铁梯度与ROS(超氧化物、羟基自由基和一氧化氮)的积累被认为是所有这些疾病中神经元毒性和死亡的主要触发因素。因此,神经退行性疾病和衰老的未来有效治疗取决于能否获得有效的可透过血脑屏障、具有铁螯合/自由基清除作用的神经保护药物,以防止神经退行性变的进展。据报道,茶类黄酮(儿茶素)具有强大的铁螯合、自由基清除和抗炎活性,并能在多种神经疾病的细胞和动物模型中保护神经元免于死亡。最近的研究表明,除了已知的儿茶素抗氧化活性外,其他机制,如信号转导通路的调节、细胞存活/死亡基因和线粒体功能的调节,对细胞活力的诱导也有显著贡献。本综述将聚焦于绿茶及其主要成分(-)-表没食子儿茶素-3-没食子酸酯(EGCG)的多功能特性,以及它们在体外和体内诱导神经保护和神经拯救的能力。特别是它们对过渡金属(铁和铜)的螯合特性以及对氧化应激的抑制作用。